CRISPR Therapeutics
CRISPR Therapeutics
crisprtx.com

Locations

London, UK · Basel, Switzerland · Massachusetts, USA · Switzerland · United States · United Kingdom · North America · Cambridge, MA, USA · Cambridge, MA, USA

industry

Biotechnology · DeepTech · Health

Size

201-1000 employees

Stage

Other

founded in

2013

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. They have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from their scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. CRISPR Therapeutics’ vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. The company is headquartered in Basel, Switzerland and has operations in London, UK.

Something looks off?
Open jobs at CRISPR Therapeutics

On-site & Remote